INSY
Insys Therapeutics, Inc.
INSY
INSY
Delisted
INSY was delisted on the 18th of June, 2019.
99 hedge funds and large institutions have $352M invested in Insys Therapeutics, Inc. in 2014 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 39 increasing their positions, 26 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
39% less call options, than puts
Call options by funds: $2.61M | Put options by funds: $4.25M
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
99
Holding in Top 10
1
Calls
$2.61M
Puts
$4.25M
Top Buyers
| 1 | +$25M | |
| 2 | +$24.5M | |
| 3 | +$24.2M | |
| 4 |
CCM
Consonance Capital Management
New York
|
+$12.1M |
| 5 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$7.98M |
Top Sellers
| 1 | -$20.3M | |
| 2 | -$19.8M | |
| 3 | -$6.33M | |
| 4 |
Renaissance Technologies
New York
|
-$5.68M |
| 5 |
Two Sigma Investments
New York
|
-$4.02M |